The US Food and Drug Administration (FDA) has announced plans to restrict COVID-19 vaccine access to individuals 65 years old and above, as well as those at high risk of severe illness from infection. Manufacturers will now be required to conduct clinical trials demonstrating the vaccines’ benefits for healthy younger adults and children. This shift in policy comes after FDA leaders signaled a change in thinking, citing that widespread COVID-19 vaccination has offered many people some level of immunity through vaccinations or infections alone.
Source: https://www.statnews.com/2025/05/20/fda-vaccine-framework-new-covid-shot-recommendations-vinay-prasad-marty-makary